A citation-based method for searching scientific literature

Raygene Martier, Pavlina Konstantinova. Front Neurosci 2020
Times Cited: 7







List of co-cited articles
30 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Engineered AAVs for efficient noninvasive gene delivery to the central and peripheral nervous systems.
Ken Y Chan, Min J Jang, Bryan B Yoo, Alon Greenbaum, Namita Ravi, Wei-Li Wu, Luis Sánchez-Guardado, Carlos Lois, Sarkis K Mazmanian, Benjamin E Deverman,[...]. Nat Neurosci 2017
360
42

Rescue of the spinal muscular atrophy phenotype in a mouse model by early postnatal delivery of SMN.
Kevin D Foust, Xueyong Wang, Vicki L McGovern, Lyndsey Braun, Adam K Bevan, Amanda M Haidet, Thanh T Le, Pablo R Morales, Mark M Rich, Arthur H M Burghes,[...]. Nat Biotechnol 2010
507
42

Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes.
Kevin D Foust, Emily Nurre, Chrystal L Montgomery, Anna Hernandez, Curtis M Chan, Brian K Kaspar. Nat Biotechnol 2009
795
42

Adeno-Associated Virus-Based Gene Therapy for CNS Diseases.
Michaël Hocquemiller, Laura Giersch, Mickael Audrain, Samantha Parker, Nathalie Cartier. Hum Gene Ther 2016
143
42

Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells.
S M Elbashir, J Harborth, W Lendeckel, A Yalcin, K Weber, T Tuschl. Nature 2001
28

Therapies targeting DNA and RNA in Huntington's disease.
Edward J Wild, Sarah J Tabrizi. Lancet Neurol 2017
133
28

A divalent siRNA chemical scaffold for potent and sustained modulation of gene expression throughout the central nervous system.
Julia F Alterman, Bruno M D C Godinho, Matthew R Hassler, Chantal M Ferguson, Dimas Echeverria, Ellen Sapp, Reka A Haraszti, Andrew H Coles, Faith Conroy, Rachael Miller,[...]. Nat Biotechnol 2019
41
28

Non viral vectors in gene therapy- an overview.
Murali Ramamoorth, Aparna Narvekar. J Clin Diagn Res 2015
283
28


Gene suppression approaches to neurodegeneration.
Rhia Ghosh, Sarah J Tabrizi. Alzheimers Res Ther 2017
24
28


Severe Toxicity in Nonhuman Primates and Piglets Following High-Dose Intravenous Administration of an Adeno-Associated Virus Vector Expressing Human SMN.
Christian Hinderer, Nathan Katz, Elizabeth L Buza, Cecilia Dyer, Tamara Goode, Peter Bell, Laura K Richman, James M Wilson. Hum Gene Ther 2018
262
28

AAV4-mediated expression of IGF-1 and VEGF within cellular components of the ventricular system improves survival outcome in familial ALS mice.
James C Dodge, Christopher M Treleaven, Jonathan A Fidler, Mark Hester, Amanda Haidet, Chalonda Handy, Meghan Rao, Amy Eagle, Jennifer C Matthews, Tatyana V Taksir,[...]. Mol Ther 2010
85
28

AAV5-miHTT Gene Therapy Demonstrates Broad Distribution and Strong Human Mutant Huntingtin Lowering in a Huntington's Disease Minipig Model.
Melvin M Evers, Jana Miniarikova, Stefan Juhas, Astrid Vallès, Bozena Bohuslavova, Jana Juhasova, Helena Kupcova Skalnikova, Petr Vodicka, Ivona Valekova, Cynthia Brouwers,[...]. Mol Ther 2018
63
28

CNS-targeted viral delivery of G-CSF in an animal model for ALS: improved efficacy and preservation of the neuromuscular unit.
Alexandre Henriques, Claudia Pitzer, Tanjew Dittgen, Matthias Klugmann, Luc Dupuis, Armin Schneider. Mol Ther 2011
43
28

Single-Dose Gene-Replacement Therapy for Spinal Muscular Atrophy.
Jerry R Mendell, Samiah Al-Zaidy, Richard Shell, W Dave Arnold, Louise R Rodino-Klapac, Thomas W Prior, Linda Lowes, Lindsay Alfano, Katherine Berry, Kathleen Church,[...]. N Engl J Med 2017
862
28

Targeting RNA-Mediated Toxicity in C9orf72 ALS and/or FTD by RNAi-Based Gene Therapy.
Raygene Martier, Jolanda M Liefhebber, Ana García-Osta, Jana Miniarikova, Mar Cuadrado-Tejedor, Maria Espelosin, Susana Ursua, Harald Petry, Sander J van Deventer, Melvin M Evers,[...]. Mol Ther Nucleic Acids 2019
40
28

Gene and protein therapies utilizing VEGF for ALS.
Orion P Keifer, Deirdre M O'Connor, Nicholas M Boulis. Pharmacol Ther 2014
32
28

Adeno-associated virus-mediated delivery of a recombinant single-chain antibody against misfolded superoxide dismutase for treatment of amyotrophic lateral sclerosis.
Priyanka Patel, Jasna Kriz, Mathieu Gravel, Geneviève Soucy, Christine Bareil, Claude Gravel, Jean-Pierre Julien. Mol Ther 2014
78
28

Cre-dependent selection yields AAV variants for widespread gene transfer to the adult brain.
Benjamin E Deverman, Piers L Pravdo, Bryan P Simpson, Sripriya Ravindra Kumar, Ken Y Chan, Abhik Banerjee, Wei-Li Wu, Bin Yang, Nina Huber, Sergiu P Pasca,[...]. Nat Biotechnol 2016
412
28

An antisense oligonucleotide against SOD1 delivered intrathecally for patients with SOD1 familial amyotrophic lateral sclerosis: a phase 1, randomised, first-in-man study.
Timothy M Miller, Alan Pestronk, William David, Jeffrey Rothstein, Ericka Simpson, Stanley H Appel, Patricia L Andres, Katy Mahoney, Peggy Allred, Katie Alexander,[...]. Lancet Neurol 2013
390
28

Delayed disease onset and extended survival in the SOD1G93A rat model of amyotrophic lateral sclerosis after suppression of mutant SOD1 in the motor cortex.
Gretchen M Thomsen, Genevieve Gowing, Jessica Latter, Maximus Chen, Jean-Philippe Vit, Kevin Staggenborg, Pablo Avalos, Mor Alkaslasi, Laura Ferraiuolo, Shibi Likhite,[...]. J Neurosci 2014
83
28

Nusinersen versus Sham Control in Infantile-Onset Spinal Muscular Atrophy.
Richard S Finkel, Eugenio Mercuri, Basil T Darras, Anne M Connolly, Nancy L Kuntz, Janbernd Kirschner, Claudia A Chiriboga, Kayoko Saito, Laurent Servais, Eduardo Tizzano,[...]. N Engl J Med 2017
781
28

Engineering adeno-associated virus vectors for gene therapy.
Chengwen Li, R Jude Samulski. Nat Rev Genet 2020
182
28

AAV5-miHTT gene therapy demonstrates suppression of mutant huntingtin aggregation and neuronal dysfunction in a rat model of Huntington's disease.
J Miniarikova, V Zimmer, R Martier, C C Brouwers, C Pythoud, K Richetin, M Rey, J Lubelski, M M Evers, S J van Deventer,[...]. Gene Ther 2017
38
28

Adeno-associated virus vector as a platform for gene therapy delivery.
Dan Wang, Phillip W L Tai, Guangping Gao. Nat Rev Drug Discov 2019
398
28

CRISPR/Cas9 Mediated Disruption of the Swedish APP Allele as a Therapeutic Approach for Early-Onset Alzheimer's Disease.
Bence György, Camilla Lööv, Mikołaj P Zaborowski, Shuko Takeda, Benjamin P Kleinstiver, Caitlin Commins, Ksenia Kastanenka, Dakai Mu, Adrienn Volak, Vilmantas Giedraitis,[...]. Mol Ther Nucleic Acids 2018
57
28

Gene therapy for neurological disorders: progress and prospects.
Benjamin E Deverman, Bernard M Ravina, Krystof S Bankiewicz, Steven M Paul, Dinah W Y Sah. Nat Rev Drug Discov 2018
115
28

Recent progress and considerations for AAV gene therapies targeting the central nervous system.
Erik Allen Lykken, Charles Shyng, Reginald James Edwards, Alejandra Rozenberg, Steven James Gray. J Neurodev Disord 2018
60
28

A large animal model of spinal muscular atrophy and correction of phenotype.
Sandra I Duque, W David Arnold, Philipp Odermatt, Xiaohui Li, Paul N Porensky, Leah Schmelzer, Kathrin Meyer, Stephen J Kolb, Daniel Schümperli, Brian K Kaspar,[...]. Ann Neurol 2015
78
28

Circulating microRNAs in Huntington's disease: Emerging mediators in metabolic impairment.
C Díez-Planelles, P Sánchez-Lozano, M C Crespo, J Gil-Zamorano, R Ribacoba, N González, E Suárez, A Martínez-Descals, P Martínez-Camblor, V Álvarez,[...]. Pharmacol Res 2016
43
14

Benton Judgment of Line Orientation (JoLO) Test: A Brief and Useful Measure for Assessing Visuospatial Abilities in Manifest, but not Premanifest, Huntington's Disease.
Jody Corey-Bloom, Shea Gluhm, Andrew Herndon, Ameera S Haque, Sungmee Park, Paul E Gilbert. J Huntingtons Dis 2016
6
16

8OHdG as a marker for Huntington disease progression.
Jeffrey D Long, Wayne R Matson, Andrew R Juhl, Blair R Leavitt, Jane S Paulsen. Neurobiol Dis 2012
43
14

Bone marrow transplantation confers modest benefits in mouse models of Huntington's disease.
Wanda Kwan, Anna Magnusson, Austin Chou, Anthony Adame, Monica J Carson, Shinichi Kohsaka, Eliezer Masliah, Thomas Möller, Richard Ransohoff, Sarah J Tabrizi,[...]. J Neurosci 2012
52
14

Uric Acid as a Potential Peripheral Biomarker for Disease Features in Huntington's Patients.
Jody Corey-Bloom, Ameera Haque, Sameer Aboufadel, Chase Snell, Ryan S Fischer, Steven W Granger, Douglas A Granger, Elizabeth A Thomas. Front Neurosci 2020
6
16

Potential biomarkers to follow the progression and treatment response of Huntington's disease.
Marie-Hélène Disatnik, Amit U Joshi, Nay L Saw, Mehrdad Shamloo, Blair R Leavitt, Xin Qi, Daria Mochly-Rosen. J Exp Med 2016
25
14

PET Imaging in Huntington's Disease.
Andreas-Antonios Roussakis, Paola Piccini. J Huntingtons Dis 2015
6
16

HTRF analysis of soluble huntingtin in PHAROS PBMCs.
Miriam Moscovitch-Lopatin, Rachel E Goodman, Shirley Eberly, James J Ritch, H Diana Rosas, Samantha Matson, Wayne Matson, David Oakes, Anne B Young, Ira Shoulson,[...]. Neurology 2013
6
16

Validation of plasma branched chain amino acids as biomarkers in Huntington disease.
Fanny Mochel, Sandra Benaich, Daniel Rabier, Alexandra Durr. Arch Neurol 2011
29
14

Mechanisms of protein toxicity in neurodegenerative diseases.
Chang Geon Chung, Hyosang Lee, Sung Bae Lee. Cell Mol Life Sci 2018
51
14

Salt-responsive gut commensal modulates TH17 axis and disease.
Nicola Wilck, Mariana G Matus, Sean M Kearney, Scott W Olesen, Kristoffer Forslund, Hendrik Bartolomaeus, Stefanie Haase, Anja Mähler, András Balogh, Lajos Markó,[...]. Nature 2017
444
14

Cystathionine Levels in Patients With Huntington Disease.
N A Aziz, W Onkenhout, H J Kerstens, Raymund A C Roos. PLoS Curr 2015
5
20

Gut dysbiosis in Huntington's disease: associations among gut microbiota, cognitive performance and clinical outcomes.
Cory I Wasser, Emily-Clare Mercieca, Geraldine Kong, Anthony J Hannan, Sonja J McKeown, Yifat Glikmann-Johnston, Julie C Stout. Brain Commun 2020
15
14

Changes of peripheral TGF-β1 depend on monocytes-derived macrophages in Huntington disease.
Alba Di Pardo, Silvia Alberti, Vittorio Maglione, Enrico Amico, Etty P Cortes, Francesca Elifani, Giuseppe Battaglia, Carla L Busceti, Ferdinando Nicoletti, Jean Paul G Vonsattel,[...]. Mol Brain 2013
13
14

Study of plasma-derived miRNAs mimic differences in Huntington's disease brain.
Andrew G Hoss, Valentina N Lagomarsino, Samuel Frank, Tiffany C Hadzi, Richard H Myers, Jeanne C Latourelle. Mov Disord 2015
22
14

Increased oxidative damage and mitochondrial abnormalities in the peripheral blood of Huntington's disease patients.
Chiung-Mei Chen, Yih-Ru Wu, Mei-Ling Cheng, Jun-Liang Liu, Yu-May Lee, Po-Wei Lee, Bing-Wen Soong, Daniel Tsun-Yee Chiu. Biochem Biophys Res Commun 2007
155
14

Blood-based 8-hydroxy-2'-deoxyguanosine level: A potential diagnostic biomarker for atrial fibrillation.
Jin Li, Deli Zhang, Kennedy S Ramos, Luciënne Baks, Marit Wiersma, Eva A H Lanters, Ad J J C Bogers, Natasja M S de Groot, Bianca J J M Brundel. Heart Rhythm 2021
6
16

Ultrasensitive measurement of huntingtin protein in cerebrospinal fluid demonstrates increase with Huntington disease stage and decrease following brain huntingtin suppression.
Amber L Southwell, Stephen E P Smith, Tessa R Davis, Nicholas S Caron, Erika B Villanueva, Yuanyun Xie, Jennifer A Collins, Min Li Ye, Aaron Sturrock, Blair R Leavitt,[...]. Sci Rep 2015
48
14

Detection of Huntington's disease decades before diagnosis: the Predict-HD study.
J S Paulsen, D R Langbehn, J C Stout, E Aylward, C A Ross, M Nance, M Guttman, S Johnson, M MacDonald, L J Beglinger,[...]. J Neurol Neurosurg Psychiatry 2008
533
14

Host microbiota constantly control maturation and function of microglia in the CNS.
Daniel Erny, Anna Lena Hrabě de Angelis, Diego Jaitin, Peter Wieghofer, Ori Staszewski, Eyal David, Hadas Keren-Shaul, Tanel Mahlakoiv, Kristin Jakobshagen, Thorsten Buch,[...]. Nat Neurosci 2015
14


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.